OIM
AXDX

Oracle Investment Management’s Accelerate Diagnostics AXDX Stock Holding History

Oracle Investment Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,790
Closed -$686K – 21
2020
Q2 		$686K Sell
13,790
-25,050
-64% -$2.47M 0.09% 19
2020
Q1 		$55K Sell
38,840
-9,510
-20% -$1.34M 0.02% 18
2019
Q4 		$1.5M Sell
48,350
-41,660
-46% -$6.88M 0.28% 17
2019
Q3 		$687K Buy
90,010
+72,010
+400% +$13.9M 0.17% 18
2019
Q2 		$808K Sell
18,000
-2,640
-13% -$516K 0.17% 16
2019
Q1 		$377K Sell
20,640
-40,710
-66% -$7.63M 0.08% 17
2018
Q4 		$405K Sell
61,350
-35,440
-37% -$5.25M 0.13% 15
2018
Q3 		$2.99M Buy
96,790
+36,030
+59% +$7.97M 0.66% 13
2018
Q2 		$2.11M Buy
60,760
+9,120
+18% +$2.04M 0.51% 13
2018
Q1 		$910K Buy
51,640
+24,140
+88% +$6.34M 0.22% 20
2017
Q4 		$2.53M Sell
27,500
-18,380
-40% -$4.31M 0.5% 16
2017
Q3 		$897K Buy
45,880
+8,590
+23% +$2.11M 0.15% 18
2017
Q2 		$1.97M Buy
37,290
+27,290
+273% +$7.4M 0.31% 14
2017
Q1 		$475K Buy
+10,000
New +$2.28M 0.07% 18

Other funds holding AXDX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oracle Investment Management's AXDX Position: Q2 2024 in Review

Oracle Investment Management sold out of Accelerate Diagnostics (AXDX) in Q2 2024, closing a stake of 42,101 shares — an estimated $41.7K sold.

Oracle Investment Management first reported a position in AXDX in Q2 2013 and held it in 44 quarters. The position peaked at $140M in Q2 2014. 41 funds tracked by Wall St. Rank hold AXDX as of Q2 2024.

  • Oracle Investment Management reported no remaining Accelerate Diagnostics position as of Q2 2024 after selling out during the quarter.
  • Oracle Investment Management sold 42,101 Accelerate Diagnostics shares in Q2 2024, an estimated $41.7K.
  • Oracle Investment Management first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 44 quarters.
  • Oracle Investment Management's Accelerate Diagnostics position peaked at $140M in Q2 2014.
  • 41 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2024.

Based on Oracle Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.